# RESTART C0168Z05 Rheumatoid Arthritis Study

> **NCT00714493** · PHASE4 · COMPLETED · sponsor: **Centocor Ortho Biotech Services, L.L.C.** · enrollment: 203 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT00714493
- **Lead sponsor:** Centocor Ortho Biotech Services, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-06
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2013-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714493, "RESTART C0168Z05 Rheumatoid Arthritis Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00714493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*